 May 29, 2007
|
Lipid Problems Explored in Women
(Reuters Health)
Untreated HIV-infected women have lower levels of high-density lipoprotein cholesterol (HDL-C) and higher triglyceride levels compared with uninfected women, according to data from the Women's Interagency HIV Study. This pattern is aggravated by treatment that includes protease inhibitors.
|
|
May 25, 2007
|
'Serosorting' Risk can be High
(AIDSmeds.com)
A new mathematical model study suggests that, in some circumstances, serosorting may be associated with a higher risk of HIV infection, largely due to recently infected individuals still thinking and disclosing that they are seronegative.
|
|
May 23, 2007
|
Some Do Well After Treatment Interruption
(Reuters Health)
Treatment interruption appears safe in a subgroup of HIV patients with
preserved immune function, researchers report in the May 15th issue of
the Journal of Infectious Diseases.
|
|
May 22, 2007
May 18, 2007
|
HIV Vaccines May Work in Unexpected Ways
(AIDSmeds.com)
Even if current top HIV vaccine candidates do not prevent infection, they may still prove beneficial by prolonging disease-free survival and reducing secondary viral transmission.
|
|
|
Accurate Immune System Marker in Poor Countries
(Reuters Health)
A new algorithm based on components of a complete blood cell count (CBC) gives a better estimate of CD4 cell count in HIV patients than estimates using the total lymphocyte count (TLC).
|
|
May 17, 2007
|
Spinal Chemicals May Predict HIV Dementia Risk
(Reuters Health)
Various biomarkers indicate risk for development of HIV-associated
dementia and for worsening of the condition, according to a report in
the May 1st issue of Neurology.
|
|
May 16, 2007
|
Pubic Lipomas a Lipo Symptom?
(Reuters Health)
A distinctive suprapubic fat pad is often present in patients with HIV-associated lipodystrophy, but it is often overlooked, Italian researchers report in the May 1st issue of the Journal of Acquired Immune Deficiency Syndrome.
|
|
May 15, 2007
|
Study Finds Abacavir Allergy Screening Useful
(Reuters Health)
Hypersensitivity to abacavir can be detected by screening for HLA-B*5701 and is recommended for HIV-infected individuals who are candidates for the antiviral agent, French researchers report.
|
|
May 14, 2007
|
Kaletra Regimens 'Forgiving' of Missed Doses
(Reuters Health)
Adherence rates to lopinavir/ritonavir regimens that fall below 95% can still bring about high rates of virologic suppression in HIV infection, according to a new study.
|
|
May 11, 2007
|
No Drop in Non-AIDS Cancer Rates
(Reuters Health)
The effect of highly active antiretroviral therapy (HAART) on the incidence of non-AIDS-defining cancers in adults with AIDS is variable, with little effect seen in many instances, according to a report in the May 15th American Journal of Epidemiology.
|
|
May 10, 2007
|
PIs and Non-Nukes Cause Similar Metabolic Problems
(Reuters Health)
The long-term metabolic consequences of antiretroviral therapy (ART) are similar with protease inhibitors (PI), nonnucleoside reverse transcriptase inhibitors (NNRTI), or the combination thereof, according to a report in the April 15th issue of the Journal of Acquired Immune Deficiency Syndromes.
|
|
May 08, 2007
|
Study Explores Lipid Problems in Women
(AIDSmeds.com)
New data indicate that lipid problems can vary, depending on a woman’s HIV status, whether or not she’s on HIV treatment, or which antiretrovirals she is using.
|
|
|
Hysterectomy Rates Higher in Women with HIV
(Reuters Health)
Compared to seronegative at-risk women, those with HIV are more likely to undergo hysterectomy over a 5-year period. However, after adjustment, the difference does not reach significance.
|
|
May 04, 2007
|
Uncommon Causes of Stroke More Frequent in HIV
(Reuters Health)
Atypical mechanisms of ischemic stroke are more common in HIV-infected patients than in the general population, according to a report in the April 17th issue of Neurology.
|
|
|
Green Tea for HIV Dementia
(Reuters Health)
A compound derived from green tea greatly diminished the neurotoxicity of proteins secreted by HIV in a study involving mice suggesting a new approach to prevent and treat HIV-associated dementia.
|
|
May 03, 2007
|
HIV Treatment Good for Growth in Kids
(Reuters Health)
HIV-infected children treated with highly active antiretroviral therapy
(HAART) experience significant catch-up in height and weight, according
to a report in the April issue of The Pediatric Infectious Disease
Journal.
|
|
May 02, 2007
|
Race, Mental Health Affect HIV Treatment
(Reuters Health)
Race and psychiatric disorders influence the risk of highly active antiretroviral therapy (HAART) failure, according to a report by researchers at Walter Reed Army Naval Medical Center, Washington, DC.
|
|
|
Possible Lipo Drug Dropkicks Glucose
(AIDSmeds.com)
A drug currently being studied as a lipodystrophy treatment may have an advantage of other compounds in development ? an ability to reduce blood glucose levels, a common problem in people with lipodystrophy.
|
|
May 01, 2007
|
